Moreover, the observed cell fitness phenotype was not fully penetrant for any particular cancer- or tissue-type, suggesting that rather the cell-specific genetic make-up determines whether TRIM52 targeting confers a decrease in fitness. The gene discussed is TRIM52; the disease is cancer.